ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Tang speaks with ecancertv at ESMO 2016 about successes with ANG1005, a conjugate of paclitaxel with a peptide which can cross the blood brain barrier.
He describes the mechanism of the molecules infiltration and action within brain metastases of breast cancer, and considers further avenues for development through modified conjugates, and treatment of primary brain lesions.
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert round up July 28th to August 3rd, 2023